Introduction
The Indian cosmetic industry is a $25+ billion market growing at 10-12% CAGR. From fairness creams to K-beauty imports, from ayurvedic ubtan to luxury perfumes, cosmetics have moved from “luxury” to “lifestyle essential”.
But tax law still treats them as “sin goods”. Under GST, most cosmetics attract 28% – the highest slab. This creates legal tension: if toothpaste is at 18% for hygiene, why is sunscreen at 18% per AAR but SPF 50+ products still litigating?
This article analyzes how taxation law treats the cosmetic industry under GST, Income Tax, Customs, and the Drugs & Cosmetics Act 1940 that defines everything.
Facts / Industry & Tax Landscape
The market is 85% controlled by FMCG majors like HUL, Emami, Dabur + MNCs like L’Oréal, P&G, with D2C brands like Mamaearth, Plum, Nykaa disrupting distribution. Product mix is 42% skincare, 26% haircare, 20% color cosmetics, 12% fragrances. “Ayurvedic/Natural” is the fastest growing sub-segment.
Indian Cosmetic Market Structure
| Segment | Market Share |
|---|---|
| Skincare | 42% |
| Haircare | 26% |
| Color Cosmetics | 20% |
| Fragrances | 12% |
Major Industry Participants
- FMCG majors: HUL, Emami, Dabur
- MNC brands: L’Oréal, P&G
- D2C disruptors: Mamaearth, Plum, Nykaa
- Fastest-growing segment: Ayurvedic/Natural products
Pre-GST, excise + VAT + luxury tax meant 30-35% effective tax with cascading. Post-GST 2017, rates simplified but the rate itself stayed high. The biggest regulatory overlap is with Drugs & Cosmetics Act 1940, because many products claim dual status as “cosmetic + ayurvedic drug”, which directly decides tax rate.
Pre-GST vs Post-GST Tax Treatment
| Period | Tax Structure | Key Feature |
|---|---|---|
| Pre-GST | Excise + VAT + Luxury Tax | 30-35% effective tax with cascading effect |
| Post-GST (2017 onwards) | GST-based taxation | Simplified structure but high tax rates remain |
3. Legal Implications / Key Tax Issues
GST Classification Disputes
GST disputes center on 28% vs 18% classification. Entry 221 of Schedule IV taxes “beauty/make-up preparations” at 28%, while Entry 182 taxes “soap, shampoo, toothpaste” at 18%. The fight is whether anti-dandruff shampoo is medicament or cosmetic, whether sunscreen is suncare or skin protectant. “Cosmeceutical” products with retinol, vitamin C, SPF 50+ claim therapeutic benefit, so companies argue 12% as medicament under Entry 180 while tax dept argues 28%.
Major GST Classification Controversies
- Anti-dandruff shampoo: Medicament or cosmetic?
- Sunscreen products: Suncare or skin protectant?
- SPF 50+ formulations: Therapeutic or cosmetic use?
- Cosmeceuticals containing retinol and vitamin C
- Ayurvedic cosmetic products claiming medicinal benefits
| Product Category | Taxpayer Position | Department Position |
|---|---|---|
| Cosmeceuticals | 12% as medicament under Entry 180 | 28% as cosmetic product |
| Anti-dandruff Shampoo | Medicament | Cosmetic |
| Sunscreen/SPF 50+ | Skin protectant | Beauty preparation |
Income Tax Issues in Cosmetic Industry
Income Tax issues arise on Sec 37(1) deductions for ads and influencer fees, though freebies to doctors are disallowed per MCI ethics + CBDT Circular 5/2012. Sec 40A(2) scrutinizes royalty payments to foreign parents for brand use by L’Oréal, Nivea etc. Sec 194R now imposes 10% TDS on benefits to influencers/doctors above ₹20,000, creating compliance burden even for PR kits worth ₹5,000.
Key Income Tax Provisions
- Section 37(1) – Deduction of advertising and influencer expenses.
- CBDT Circular 5/2012 – Disallowance of freebies to doctors.
- Section 40A(2) – Scrutiny of royalty payments to foreign parent entities.
- Section 194R – 10% TDS on benefits/perquisites exceeding ₹20,000.
| Provision | Issue | Impact |
|---|---|---|
| Sec 37(1) | Advertising and influencer fee deductions | Tax deductibility disputes |
| CBDT Circular 5/2012 | Doctor freebies | Expense disallowance |
| Sec 40A(2) | Foreign royalty payments | Transfer pricing scrutiny |
| Sec 194R | Influencer and doctor benefits | 10% TDS compliance burden |
Customs Duty and Import Disputes
Customs duty is 20% BCD + 10% social welfare cess = 22% total for imports under HS Code 3304. Misdeclaration between 3304 “cosmetics” and 3004 “medicaments” leads to penalties. E-commerce imports via courier create valuation disputes under Courier Imports Rules.
Customs Compliance Risks
- Classification disputes between HS Code 3304 and HS Code 3004.
- Penalties arising from misdeclaration of imported products.
- Valuation disputes under Courier Imports Rules.
- E-commerce import compliance challenges.
| Customs Component | Rate |
|---|---|
| Basic Customs Duty (BCD) | 20% |
| Social Welfare Cess | 10% of BCD |
| Effective Customs Burden | 22% |
Key Takeaways on Cosmetic Taxation
- Most cosmetics continue to attract GST at the 28% rate.
- Classification disputes remain the biggest source of litigation.
- Dual-status products classified as both cosmetic and ayurvedic drug create regulatory complexity.
- Influencer marketing now attracts additional TDS compliance requirements.
- Imported cosmetics face significant customs duty exposure and classification risks.
- The Drugs & Cosmetics Act 1940 continues to influence GST and customs classification outcomes.
Drugs & Cosmetics Act 1940 – The Foundation of Tax Classification
Tax law borrows its definitions directly from this Act, so classification disputes always start here.
Section 3(a): Definition of “Drug”
Section 3(a) defines “Drug” as any substance for diagnosis, treatment, mitigation, or prevention of disease in humans. If your product claims to “cure acne”, “treat dandruff”, or “prevent skin cancer”, it’s a drug.
Section 3(b): Definition of “Cosmetic”
Section 3(b) defines “Cosmetic” as any article for cleansing, beautifying, promoting attractiveness, or altering appearance. The focus is “beautifying”, not “healing”. Rule 129 of D&C Rules 1945 lists creams, lotions, lipsticks, shampoos, toothpaste as cosmetics, but specifically excludes soap.
Licensing & Control
Cosmetics need intimation under Rule 21 to State Drug Controller. Drugs need full manufacturing license and clinical trials. This license type becomes evidence in tax litigation. Tax dept asks: “Is it licensed as drug or cosmetic?”
Label Claims Test
Section 10 prohibits false/misleading claims. Courts use this in tax cases. Hindustan Lever v State of Maharashtra held “Fair & Lovely” is cosmetic because it claims to “beautify skin tone”, not “cure disease”. So sunscreen labeled “prevents tanning” = cosmetic, but “prevents skin cancer” = drug.
Core Problem: Cosmeceuticals
The Act has only two boxes – drug or cosmetic. But 2025 has “cosmeceuticals” with actives like Vitamin C, peptides, SPF 100 that both beautify and treat. D&C Act is silent, so tax dept defaults to 28% cosmetic. The Draft Drugs, Medical Devices & Cosmetics Bill 2023 finally proposes a third category for cosmeceuticals, which would solve most GST disputes.
Difference Between Cosmetic & Medicament
The “primary purpose test” from BPL Pharmaceuticals v CCE and Hindustan Lever v State of Maharashtra is the judicial standard.
| Particulars | Cosmetic | Medicament |
|---|---|---|
| Definition | Any article for cleansing, beautifying, or altering appearance. | Any preparation for diagnosis, treatment, mitigation, or prevention of disease/ailment. |
| Purpose | Main purpose is aesthetic. | Main purpose is therapeutic. |
| Ingredients | May contain vitamins or mild actives. | Must contain proven therapeutic ingredients. |
| Examples | Lipstick, foundation, perfume, regular shampoo, moisturizer with vitamin E. | Shampoo with ketoconazole for dandruff, acne gel with clindamycin, sunscreen labeled “prevents skin cancer”. |
| GST Treatment | 28% under Entry 221 unless specifically listed at 18%. | 12% under Entry 180 as medicament. |
Judicial Tests for Classification
Courts look at three things:
- Label claims
- Consumer perception
- Predominant use
If a product “beautifies”, it stays cosmetic even with actives. If it “cures”, it’s medicament even if it also cleans. This thin line is why anti-dandruff shampoo, medicated soap, and SPF 50+ sunscreen are constant litigation targets.
What Cosmetic Products Can Be Taxed & What Not
Products Taxed at 28% GST
Most beauty products are taxed at 28% GST under Entry 221. This includes:
- Lipsticks
- Nail polish
- Foundation
- Face creams
- Lotions
- Perfumes
- Deodorants
- Makeup kits
- Hair styling gels
- General skincare without medical claims³
Products Taxed at 18% GST
Essential hygiene products are carved out to 18% under Entry 182. This includes:
- Soaps
- Shampoos
- Toothpaste
- Tooth powder
- Hair oil
- Talcum powder⁴
Sunscreens are at 18% as per Karnataka AAR 2021¹⁷, but SPF 50+ products claiming “broad spectrum protection” still face 28% demands from tax officers.
Products Taxed at 12% GST
True medicaments with therapeutic claims fall at 12% under Entry 180. This includes:
- Anti-dandruff shampoos with drugs
- Medicated soaps for skin disease
- Acne gels
- Ayurvedic drugs registered under D&C Act⁵
The product must have drug license, not just cosmetic intimation.
Exports, Samples and Influencer Distribution
- Exports of cosmetics are zero-rated under GST with ITC refund¹⁸.
- Free samples without commercial value can avoid GST.
- Sec 194R TDS still applies if given to influencers/doctors⁹.
The Cosmeceutical Classification Gap
The real gap is cosmeceuticals – a vitamin C serum that “brightens” and “reduces pigmentation” gets forced into 28% cosmetic unless the brand obtains drug license, which most avoid due to cost and clinical trial burden.
Quick Tax Classification Summary
| Category | Examples | GST Rate | Key Requirement |
|---|---|---|---|
| Cosmetics | Lipsticks, perfumes, face creams, makeup kits | 28% | Beautifying purpose |
| Hygiene Products | Soap, shampoo, toothpaste, hair oil | 18% | Specific GST entry benefit |
| Medicaments | Acne gels, medicated soaps, anti-dandruff shampoos | 12% | Drug license and therapeutic claim |
| Exports of Cosmetics | Export supplies | Zero-Rated | Eligible for ITC refund |
Key Judgments on Cosmetics and Taxation
The classification of cosmetics, medicaments, and personal care products has been a recurring subject of litigation in India. Courts and tax authorities have developed principles that continue to influence GST and indirect tax classifications. The following landmark judgments provide important guidance.
1. CCE v BPL Pharmaceuticals Ltd, 1995 Supp 3 SCC 54116
Issue: Whether “Himpyrin” medicated soap was cosmetic or medicament for excise duty.
Holding: SC laid down “primary use test”. If predominant function is cleansing/beautifying, it’s cosmetic even with incidental medicinal property. If main purpose is treating disease, it’s medicament.
Tax Impact: Still the foundation for all GST classification disputes on medicated soaps, anti-dandruff shampoos, sunscreens.
2. Hindustan Lever Ltd v State of Maharashtra, 2004 9 SCC 43814
Issue: Sales tax classification of “Fair & Lovely” fairness cream.
Holding: SC held it’s cosmetic, not drug. Court looked at label “beautifies skin tone”, consumer perception, and marketing. No claim to cure disease.
Tax Impact: Established that marketing + label decide tax. Brands now avoid medical claims to stay in 28% cosmetic instead of drug license route.
3. Johnson & Johnson Ltd v CCE, 2003 146 ELT 361 SC19
Issue: “Baby Shampoo – No More Tears” classification.
Holding: SC held it’s cosmetic at lower duty. “No tears” claim is about gentleness, not curing disease. Gentle cleansing is still cosmetic function.
Tax Impact: Shows cosmetic function includes “care” but not “cure”. Important for baby care products.
4. Karnataka AAR, M/s Himalaya Drug Co, 2021, KAR ADRG 21/202117
Issue: GST rate on sunscreen with SPF 50.
Holding: AAR held sunscreen is cosmetic at 18% GST, not medicament at 12%. Reason: Prevents tanning/damage, doesn’t treat skin disease. “Protection” ≠ “treatment”.
Tax Impact: Brought clarity but SPF 100+ and “anti-photoaging” sunscreens still litigating because claims sound therapeutic.
5. Reckitt Benckiser India Ltd – GST Classification Dispute, 202220
Issue: Whether “Dettol handwash” is soap at 18% or disinfectant at 28%.
Status: Matter reached SC via SLP. Shows even hygiene products face classification war.
Tax Impact: Proves “cosmetic vs medicament” line is collapsing. Post-COVID, “antibacterial” claims push hygiene products into 28% slab.
Summary of Key Judgments
| Case | Product | Core Principle | Tax Significance |
|---|---|---|---|
| CCE v BPL Pharmaceuticals Ltd | Himpyrin Medicated Soap | Primary Use Test | Foundation for cosmetic vs medicament classification |
| Hindustan Lever Ltd v State of Maharashtra | Fair & Lovely | Consumer Perception and Marketing Test | Labels and marketing influence tax treatment |
| Johnson & Johnson Ltd v CCE | Baby Shampoo | Care is not Cure | Gentle cleansing remains a cosmetic function |
| Karnataka AAR – Himalaya Drug Co | Sunscreen SPF 50 | Protection ≠ Treatment | Sunscreen classified as cosmetic |
| Reckitt Benckiser GST Dispute | Dettol Handwash | Hygiene Product Classification | Highlights growing GST disputes in post-COVID era |
Key Takeaways from the Cases
- The primary purpose of a product remains the most important classification test.
- Consumer perception, product labeling, and marketing claims significantly influence tax treatment.
- Products that merely protect, cleanse, or beautify are generally classified as cosmetics.
- Products intended to diagnose, prevent, or treat diseases are more likely to be treated as medicaments.
- The rise of cosmeceuticals, therapeutic skincare, and wellness products is blurring the traditional distinction between cosmetics and drugs.
Conclusions and Final Thought
India’s taxation of cosmetics exposes a policy conflict between an 85-year-old regulatory framework and a science-driven modern market. The Drugs & Cosmetics Act 1940 and GST law continue to treat beauty products as luxury goods at 28%, even when dermatology proves many serve preventive health roles.
This binary classification of drug or cosmetic cannot capture cosmeceuticals, CBD skincare, or ayurvedic science that both beautify and heal. As a result, litigation fills the gap left by legislation, startups bear compliance costs that MNCs can absorb, and consumers pay tax based on labeling strategy rather than product function.
Until Parliament passes the 2023 Bill and creates a distinct category for borderline products while rationalizing rates, the law will keep taxing innovation as vanity.
Beauty may be subjective, but tax classification must be scientific. The law needs to move from asking whether a product is luxurious to asking what purpose it actually serves, because when sunscreen prevents cancer and serum treats pigmentation, calling them luxury products at 28% is no longer just outdated—it is legally indefensible.
Key Takeaways: Cosmetic Industry Taxation in India
1. Cosmetics Continue to Attract the Highest GST Slab
Most beauty and personal care products such as lipsticks, perfumes, makeup kits, face creams, and lotions are taxed at 28% GST, making cosmetics one of the highest-taxed consumer product categories in India.
2. Product Classification Determines Tax Liability
The biggest tax challenge in the cosmetic industry is classification. Whether a product is treated as a cosmetic, hygiene product, or medicament can significantly change the GST rate from 28% to 18% or even 12%.
3. The Drugs & Cosmetics Act Drives Tax Outcomes
GST authorities and courts heavily rely on the Drugs & Cosmetics Act, 1940 to determine whether a product is intended for beautification or therapeutic treatment. Licensing and product claims often become decisive factors in tax disputes.
4. Cosmeceuticals Remain a Legal Grey Area
Products containing ingredients such as Vitamin C, Retinol, Peptides, and SPF formulations often blur the line between cosmetics and medicines. The absence of a separate legal category for cosmeceuticals continues to generate significant GST litigation.
5. Marketing Claims Can Change Tax Treatment
Courts frequently examine product labels, advertisements, and consumer perception. Products claiming to “beautify” are generally classified as cosmetics, while products claiming to “treat” or “prevent disease” may qualify as medicaments.
6. Influencer Marketing Has Created New Tax Compliance Obligations
The introduction of Section 194R of the Income Tax Act requires businesses to deduct 10% TDS on benefits or perquisites exceeding ₹20,000, increasing compliance responsibilities for cosmetic brands working with influencers and healthcare professionals.
7. Imported Cosmetics Face Multiple Tax Layers
Imported beauty products are subject to Basic Customs Duty (BCD), Social Welfare Cess, and GST, resulting in a substantial tax burden. Classification disputes between cosmetic and medicament categories can further increase exposure to penalties and litigation.
8. Ayurvedic and Herbal Products Face Unique Classification Challenges
Ayurvedic beauty products frequently claim both cosmetic and therapeutic benefits. Whether they hold a drug licence or cosmetic registration often determines their GST treatment and eligibility for lower tax rates.
9. Judicial Precedents Continue to Shape Cosmetic Taxation
Landmark decisions involving products such as Fair & Lovely, Himpyrin Medicated Soap, Baby Shampoo, and Sunscreens have established important principles like the Primary Purpose Test and Consumer Perception Test, which remain relevant under GST.
10. Future Reforms May Transform Cosmetic Taxation
The proposed Drugs, Medical Devices & Cosmetics Bill, 2023 seeks to recognize emerging product categories such as cosmeceuticals. If enacted, it could reduce classification disputes and create a more scientific and consistent taxation framework for the modern beauty industry.
Cosmetic Taxation in India: Overview Table
| Key Area | Important Insight |
|---|---|
| GST Rate | Most cosmetics attract 28% GST. |
| Classification | Tax rates vary depending on whether products are classified as cosmetics, hygiene products, or medicaments. |
| Regulatory Basis | The Drugs & Cosmetics Act, 1940 plays a crucial role in determining tax treatment. |
| Cosmeceuticals | Lack of a separate legal category continues to trigger GST disputes. |
| Marketing Claims | Product labels and advertisements influence classification outcomes. |
| Influencer Marketing | Section 194R creates additional TDS compliance obligations. |
| Imported Cosmetics | BCD, Social Welfare Cess, and GST increase the overall tax burden. |
| Ayurvedic Products | Drug licences and cosmetic registrations often determine GST treatment. |
| Judicial Decisions | Consumer Perception and Primary Purpose Tests remain influential. |
| Future Reforms | The proposed legislation may reduce classification-related litigation. |
Summary
- Cosmetic GST in India remains one of the most litigated areas of indirect taxation.
- Classification between cosmetic, hygiene product, and medicament directly affects tax liability.
- Cosmeceuticals, sunscreen products, anti-dandruff shampoos, and Ayurvedic skincare products are major areas of ongoing disputes.
- Businesses must evaluate GST, Income Tax, Customs Duty, licensing requirements, and marketing claims together to ensure compliance.
- Regulatory reform is increasingly necessary to align taxation with modern cosmetic science and consumer healthcare trends.


